| 000 | 04502cam a2200385Ii 4500 | ||
|---|---|---|---|
| 001 | 95098 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112647.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 161228s2017 sz o 001 0 eng d | ||
| 020 |
_a3319460382 _q(electronic bk.) |
||
| 020 |
_a9783319460383 _q(electronic bk.) |
||
| 020 | _z3319460366 | ||
| 020 |
_z9783319460369 _q(print) |
||
| 035 |
_a(OCoLC)967282904 _z(OCoLC)967370930 _z(OCoLC)974650596 _z(OCoLC)980997599 _z(OCoLC)1005773441 _z(OCoLC)1011849147 |
||
| 040 |
_aN$T _cN$T _dIDEBK _dGW5XE _dYDX _dN$T _dAZU _dUAB _dCOO _dOCLCO _dUPM _dOCLCO _dOCLCF _dIOG _dVT2 _dOCLCO _dMERER _dESU _dJBG _dIAD _dICW _dICN _dOCLCQ _dOCLCO _dOTZ _dOCLCQ _dOCLCO _dOCLCA _dU3W _dOCLCO _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRC280.E55 _b2017 EB |
|
| 245 | 0 | 0 |
_aDiagnostic and therapeutic nuclear medicine for neuroendocrine tumors _cKarel Pacak, David Taïeb, editors. |
| 264 | 1 |
_aCham, Switzerland _bHumana Press _c2017 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 | _aContemporary endocrinology | |
| 505 | 0 | _aClassification of neuroendocrine tumors -- Molecular genetics of Pheochromocytoma and paraganglioma -- Molecular Genetics of MEN1-related Neuroendocrine Tumors -- Molecular genetics of MEN2-related neuroendocrine tumors -- Molecular genetics of Neuroblastoma -- Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors -- Current and future radiopharmaceuticals in neuroendocrine tumors imaging -- SPECT/CT, PET/CT and PET/MR: Principles -- Internal dosimetry: Principles and Applications to NET -- Principles and Application of Molecular Imaging for Personalised Medicine and Guiding Interventions in Neuroendocrine Tumors -- Tumor metabolism and metabolomics of pheochromocytomas and paragangliomas -- Radionuclide imaging of pheochromocytoma and paraganglioma in the era of multi-omics -- Radionuclide imaging of Head and neck PGLs -- Radionuclide imaging of Chromaffin cell tumors -- Radionuclide imaging of Gastrointestinal neuroendocrine tumors -- Radionuclide imaging of Pancreatic neuroendocrine tumors -- Radionuclide imaging of Pulmonary, thymic neuroendocrine tumors and other neuroendocrine tumors -- Radionuclide imaging of Medullary thyroid carcinoma -- 131I-MIBG therapy for pheochromocytoma/paraganglioma and neuroblastoma -- Somatostatin receptors-based radionuclide therapy -- Alpha radionuclide therapy: Principles and Applications to NET -- Nanoparticles for Radionuclide Imaging and Therapy: Principles. | |
| 520 | 3 | _aBased on the most novel approaches and cutting-edge clinical and scientific information regarding radionuclide imaging and therapies for neuroendocrine tumors, this clinical guidebook represents a unique collaborative effort between endocrinologists, nuclear physicians, oncologists, surgeons, physicists, radio-pharmacists and geneticists. It begins with the embryology, classification and molecular genetics of gastroenteropancreatic neuroendocrine tumors and carcinoids, chromaffin cell tumors, and MEN1- and MEN2-related tumors. Following a chapter on radiopharmaceuticals in neuroendocrine imaging, it turns to the physics and technology of current and cutting-edge radiology, including SPECT/CT and PET/CT and PET/MR. Discussing of radionuclide imaging covers the tumors mentioned above, as well as pulmonary and thymic neuroendocrine tumors and medullary thyroid carcinoma. A presentation of radionuclide therapies follows, including 131I-MIBG therapy, somatostatin receptor-based therapy, and alpha radionuclide therapy, as well as the role of nanoparticles. Comprehensive and up-to-date, Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors will assist and guide physicians who encounter patients with these conditions, either from a diagnostic or therapeutic standpoint, and particularly emphasizes the current and emerging medical devices and imaging and therapeutic options. | |
| 650 | 7 |
_aMedicina nuclear _2embne _0(OCoLC)fst01040348 _0 _9138396 |
|
| 700 | 1 |
_aPacak, Karel, _eeditor literario |
|
| 700 | 1 |
_aTaïeb, David, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-46038-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aSpringer_Medicine_2017 | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c95098 _d95098 _x1 |
||